T cell-mediated immune response to respiratory coronaviruses

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Emerging respiratory coronaviruses, including SARS-CoV and MERS-CoV, present significant biological threats, causing severe pneumonia with high mortality.
• Current research often focuses on innate immune responses to SARS-CoV, with limited exploration of adaptive immunity.
• Despite the 2002-2003 SARS epidemic, effective preventive or therapeutic agents remain unavailable.

Purpose of the Study:

• To review the critical role of T cell-mediated adaptive immunity in respiratory coronavirus infections.
• To emphasize the significance of CD4 and CD8 T cells in the context of emerging coronaviruses.
• To address the knowledge gap regarding T cell responses in coronavirus pathogenesis.

Main Methods:

• Literature review focusing on T cell responses (CD4 and CD8) in respiratory coronavirus infections.
• Analysis of studies investigating the impact of T cells on SARS-CoV and MERS-CoV pathogenesis.
• Synthesis of findings related to T cell-mediated immunity and protective mechanisms.

Main Results:

• The innate immune response is often dysregulated in SARS-CoV infections, contributing to pathology.
• Neutralizing antibody responses can be short-lived and strain-specific.
• A significant reduction in T cells is observed during the acute phase of SARS, underscoring their importance.

Conclusions:

• T cell-mediated immunity, particularly CD4 and CD8 T cells, plays a vital role in controlling respiratory coronavirus infections.
• Further research into T cell responses is crucial for developing effective countermeasures against emerging coronaviruses.
• Understanding T cell dynamics can inform the development of vaccines and therapies for future outbreaks.